Treatment of Basal Cell Carcinomas With Methyl Aminolevulinate and Daylight
1 other identifier
interventional
N/A
1 country
1
Brief Summary
Photodynamic Therapy (PDT) is an effective treatment of basal cell carcinomas (BCC) however the inconvenience of clinic attendance and discomfort during therapy are significant drawbacks. The objective of this study is to evaluate the effect of daylight-mediated PDT of BCC.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2011
CompletedFirst Submitted
Initial submission to the registry
May 5, 2011
CompletedFirst Posted
Study publicly available on registry
May 6, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedMay 6, 2011
March 1, 2011
1.8 years
May 5, 2011
May 5, 2011
Conditions
Outcome Measures
Primary Outcomes (1)
complete disappearance of the BCC
Study Arms (1)
Daylight-PDT
EXPERIMENTALInterventions
Eligibility Criteria
You may qualify if:
- superficial BCC
You may not qualify if:
- Immunosuppression
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Bispebjerg Hospital
Copenhagen NV, 2400, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 2
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
May 5, 2011
First Posted
May 6, 2011
Study Start
March 1, 2011
Primary Completion
January 1, 2013
Last Updated
May 6, 2011
Record last verified: 2011-03